BioCentury
ARTICLE | Company News

ForSight Newco II Inc., QLT deal

October 15, 2007 7:00 AM UTC

QLT will acquire ForSight for $42 million in cash. The acquisition gives QLT an ocular punctal drug delivery system, which QLT said is capable of delivering compounds to the eye through controlled rel...